Amplo Biotechnology
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.amplobiotechnology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Amplo Biotechnology
Amplo Biotechnology specializes in gene therapy for diseases affecting the neuromuscular junction, focusing on conditions such as Congenital Myasthenic Syndromes and other related disorders. Their lead products, AMP-101 and AMP-201, utilize AAV technology to deliver essential proteins for muscle function and neuromuscular health. The company is committed to serving rare and ultra-rare patient populations by employing established delivery technologies and manufacturing methods. Amplo collaborates with leading experts in the field to advance their therapies and improve the lives of patients like JJ and Max.Explore more
Amplo Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amplo Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Amplo Biotechnology launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Amplo Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Amplo Biotechnology recently announced quarterly report
Click to see if Amplo Biotechnology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Amplo Biotechnology
Check out if Amplo Biotechnology is spiking on competitors!
Funding: Get notified immidiatlly once Amplo Biotechnology has new funding data
Amplo Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Amplo Biotechnology
Compare insights from companies similar to Amplo Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amplo Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amplo Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amplo Biotechnology.
Amplo Biotechnology Tech Stack
A closer look at the technologies used by Amplo Biotechnology
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Person-Based
Funding
Project
Award, Spending/Investment, Safety, Clinical Operations, Health & Safety, Operations
Funding
Amplo Biotechnology News & Media
Amplo Biotechnology Receives Fast Track Phase I/II STTR Grant from NIH-NIAMS
Amplo Biotechnology, a San Diego, CA-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders, announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS. This grant will provide funding for the advancement of AMP-201, an AAV-ColQ gene therapy designed to address the severe congenital myasthenic syndrome […] The post Amplo Biotechnology Receives Fast Track Phase I/II STTR Grant from NIH-NIAMS appeared first on FinSMEAmplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency
SAN DIEGO, May 29, 2023 /PRNewswire/ -- Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS. This highly...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Amplo Biotechnology
Sign Up For FreeTo access detailed company insights
Amplo Biotechnology specializes in gene therapy for diseases affecting the neuromuscular junction, focusing on conditions such as Congenital Myasthenic Syndromes and other related disorders. Their lead products, AMP-101 and AMP-201, utilize AAV technology to deliver essential proteins for muscle function and neuromuscular health. The company is com... Read More
